Plantable Health Inc.
PLBL.NE · NEO
6/30/2023 | 3/31/2023 | 12/31/2022 | 9/30/2022 | |
|---|---|---|---|---|
| Revenue | CA$0 | CA$0 | CA$0 | CA$0 |
| % Growth | -79.1% | 54.1% | -9% | – |
| Cost of Goods Sold | CA$0 | CA$0 | CA$0 | CA$0 |
| Gross Profit | -CA$0 | CA$0 | CA$0 | CA$0 |
| % Margin | -9.2% | 28.3% | 13.7% | 21.6% |
| R&D Expenses | CA$0 | CA$0 | CA$0 | CA$0 |
| G&A Expenses | CA$0 | CA$0 | CA$1 | CA$1 |
| SG&A Expenses | CA$0 | CA$0 | CA$1 | CA$1 |
| Sales & Mktg Exp. | CA$0 | CA$0 | CA$0 | CA$0 |
| Other Operating Expenses | CA$0 | CA$0 | CA$0 | CA$0 |
| Operating Expenses | CA$0 | CA$0 | CA$1 | CA$1 |
| Operating Income | -CA$0 | -CA$0 | -CA$1 | -CA$1 |
| % Margin | -276.7% | -60.3% | -267.7% | -291.3% |
| Other Income/Exp. Net | -CA$0 | -CA$0 | -CA$0 | -CA$0 |
| Pre-Tax Income | -CA$0 | -CA$0 | -CA$1 | -CA$1 |
| Tax Expense | CA$0 | CA$0 | CA$0 | CA$0 |
| Net Income | -CA$0 | -CA$0 | -CA$1 | -CA$1 |
| % Margin | -276.9% | -60.9% | -275.4% | -292.5% |
| EPS | -0.003 | -0.003 | -0.01 | -0.011 |
| % Growth | 3% | 66.3% | 14% | – |
| EPS Diluted | -0.003 | -0.003 | -0.01 | -0.011 |
| Weighted Avg Shares Out | 63 | 63 | 63 | 63 |
| Weighted Avg Shares Out Dil | 63 | 63 | 63 | 63 |
| Supplemental Information | – | – | – | – |
| Interest Income | CA$0 | CA$0 | CA$0 | CA$0 |
| Interest Expense | CA$0 | CA$0 | CA$0 | CA$0 |
| Depreciation & Amortization | CA$0 | CA$0 | CA$0 | CA$0 |
| EBITDA | -CA$0 | -CA$0 | -CA$1 | -CA$1 |
| % Margin | -234.2% | -51.5% | -257.5% | -279.6% |